Tech Center 1600 • Art Units: 1637 1681
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17992674 | BLOOD DNA METHYLATION BIOMARKER DIAGNOSTIC TEST FOR ANXIETY AND DEPRESSIVE DISORDERS | Non-Final OA | Emory University |
| 17439328 | POOLED KNOCK-IN SCREENING AND HETEROLOGOUS POLYPEPTIDES CO-EXPRESSED UNDER THE CONTROL OF ENDOGENOUS LOCI | Non-Final OA | The Regents of the University of California |
| 17264734 | ANTIBIOTIC SUSCEPTIBILITY OF MICROORGANISMS AND RELATED MARKERS, COMPOSITIONS, METHODS AND SYSTEMS | Non-Final OA | California Institute of Technology |
| 17657120 | AUTHENTICATION ASSAY USING EMBEDDED DEOXYRIBONUCLEIC ACID TAGGANTS | Non-Final OA | Microsoft Technology Licensing, LLC |
| 18818523 | METHODS OF DETECTING ONCOGENIC FUSIONS AND USES THEREOF | Non-Final OA | Washington University |
| 17568854 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | Non-Final OA | Natera, Inc. |
| 17806932 | METHOD AND BIOMARKER FOR DETECTION OR DIAGNOSIS OF MYOCARDIAL INFARCTION | Final Rejection | ACADEMIA SINICA |
| 18065151 | MODEL EDITING SYSTEMS AND METHODS RELATING TO THE SAME | Non-Final OA | Pairwise Plants Services, Inc. |
| 18797835 | METHOD FOR SCREENING MULTIPLEX REVERSE TRANSCRIPTION PRIMER COMBINATIONS FOR QUANTIFYING MULTIPLE MIRNAS | Non-Final OA | MIRACLE BIOTECHNOLOGY INC. |
| 17427014 | METHODS FOR DETECTING LEGIONELLA | Final Rejection | Quest Diagnostics Investments LLC |
| 17428749 | METHODS FOR TARGETED TREATMENT AND PREDICTION OF PATIENT SURVIVAL IN CANCER | Final Rejection | University of Florida Research Foundation, Incorporated |
| 18678376 | DNA-BASED ADAPTOME PROFILING FOR MINIMAL RESIDUAL DISEASE QUANTIFICATION IN LYMPHOID MALIGNANCIES | Final Rejection | MILABORATORIES INC. |
| 17800718 | Medicine Containing USAG-1-Targeting RNA Molecule for Tooth Regeneration Therapy | Non-Final OA | Aichi Prefecture |
| 17028839 | MICROFLUIDIC SIPHONING ARRAY FOR NUCLEIC ACID QUANTIFICATION | Non-Final OA | Combinati Incorporated |
| 17419329 | STRUCTURE AND APPLICATION OF DOUBLE-STRANDED OLIGONUCLEOTIDE NUCLEIC ACID PROBE | Non-Final OA | ACADEMY OF MILITARY MEDICAL SCIENCES |
| 18156775 | MASS SPECTROMETRY-BASED KIT FOR ERYTHROCYTE BLOOD GROUP GENOTYPING | Non-Final OA | Shanghai Blood Center |
| 17996276 | USE OF AN ORPHAN MOTIF TO INCREASE EXPRESSION OF A HETEROLOGOUS TRANSGENE | Non-Final OA | FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH |
| 17891034 | COMPOSITION, KIT FOR DETECTING MUTATIONS OF 2019 NOVELCORONAVIRUS AND USE THEREOF | Non-Final OA | SANSURE BIOTECH INC. |
| 17432721 | METHODS FOR IDENTIFYING AND IMPROVING T CELL MULTIPOTENCY | Final Rejection | St. Jude Children's Research Hospital |
| 17790385 | METHOD FOR OBTAINING A MAMMALIAN CELL LINE THAT EXPRESSES A RECOMBINANT EQUINE CHORIONIC GONADOTROPIN (RECG), THE RECOMBINANT CELL LINES PRODUCING RECG, LARGE-SCALE RECG PRODUCTION METHOD, RECG, FORMULATIONS CONTAINING RECG, NUCLEIC ACIDS ENCODING FOR RECG AND USES | Non-Final OA | Natalia CEAGLIO |
| 17781480 | METHODS FOR IDENTIFYING MICROBES IN A CLINICAL AND NON-CLINICAL SETTING | Non-Final OA | Biomiris Capital Group B.V. |
| 17769721 | METHOD FOR DETECTING TARGET NUCLEIC ACID, METHOD FOR DETECTING NUCLEIC ACID-BINDING MOLECULE, AND METHOD FOR EVALUATING NUCLEIC ACID-BINDING ABILITY | Non-Final OA | EPIGENERON, INC. |
| 17609294 | EXOSOME MICRORNA AS SCHIZOPHRENIA MARKER AND USE THEREOF | Non-Final OA | Minzu University of China |
| 17281071 | SECOND GENERATION SEQUENCING-BASED METHOD FOR DETECTING MICROSATELLITE STABILITY AND GENOME CHANGES BY MEANS OF PLASMA | Non-Final OA | Guangzhou Burning Rock DX Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy